Detalles de la búsqueda
1.
T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy.
Mult Scler
; 29(6): 648-656, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36440826
2.
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.
Mult Scler
; 29(6): 719-730, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37012898
3.
Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies.
Mult Scler
; 28(1): 111-120, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33969750
4.
Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial.
Mult Scler
; 28(5): 790-800, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34382875
5.
Development and Validation of the FSIQ-RMS: A New Patient-Reported Questionnaire to Assess Symptoms and Impacts of Fatigue in Relapsing Multiple Sclerosis.
Value Health
; 22(4): 453-466, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30975397
6.
Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-ß Therapy.
J Immunol
; 194(11): 5085-93, 2015 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25917097
7.
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes.
BMC Neurol
; 14: 49, 2014 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24624979
8.
Multitasking in multiple sclerosis: can it inform vocational functioning?
Arch Phys Med Rehabil
; 94(12): 2509-2514, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23924438
9.
A retrospective claims analysis of fatigue in patients with multiple sclerosis on disease-modifying therapy.
Mult Scler Relat Disord
; 78: 104917, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37597349
10.
Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatment.
Sci Rep
; 13(1): 8067, 2023 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37202447
11.
A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study.
Neurodegener Dis Manag
; 13(5): 261-268, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37535336
12.
Multiple sclerosis: relationship between locus of control and quality of life in persons with low versus high disability.
Health Psychol Behav Med
; 10(1): 316-334, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35309243
13.
Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summary.
Neurodegener Dis Manag
; 12(1): 1-7, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35019731
14.
Relapses in people with multiple sclerosis treated with cladribine tablets followed for up to 5 years: a plain language summary.
Neurodegener Dis Manag
; 12(6): 303-310, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36017797
15.
Physician Compensation in the United States - Through the Lens of the MS Neurologist.
Mult Scler Relat Disord
; 50: 102847, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33618121
16.
Challenges in multiple sclerosis care: Results from an international mixed-methods study.
Mult Scler Relat Disord
; 50: 102854, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33690086
17.
Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets.
Front Immunol
; 12: 763433, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35003076
18.
Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis.
Mult Scler J Exp Transl Clin
; 7(3): 20552173211024298, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34345436
19.
N-acetyl cysteine administration affects cerebral blood flow as measured by arterial spin labeling MRI in patients with multiple sclerosis.
Heliyon
; 7(7): e07615, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34377857
20.
Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study.
Mult Scler J Exp Transl Clin
; 7(1): 2055217321990852, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33717501